Latest S-1 registration statements

Virpax Pharmaceuticals launches a best efforts offering of common stock and pre-funded warrants, aiming to raise approximately $4.5 million for clinical development and general corporate purposes.

iSpecimen Inc. seeks to raise up to $5 million through a best-efforts offering of common stock and pre-funded warrants to bolster its marketplace platform and address financial obligations.

FACT II Acquisition Corp., a blank check company, has filed an amendment to its Form S-1 registration statement for a proposed $175 million initial public offering.

Oaktree Acquisition Corp. III Life Sciences, a blank check company targeting the healthcare sector, files an amendment to its S-1 registration statement for a $175 million initial public offering.

Kartoon Studios plans to offer up to 10 million shares of common stock and pre-funded warrants in a best-efforts offering to bolster working capital and fund research and development.

Momentus Inc. has filed a registration statement for the potential resale of up to 20.5 million shares of its common stock by selling stockholders, related to warrants issued in a recent private placement.

Ontrak, Inc. is offering up to 6,449,481 shares of common stock issuable upon the exercise of outstanding warrants to raise capital for general corporate purposes.

SolarWindow Technologies is registering for the resale of up to 1,180,000 shares of its common stock by existing stockholders, primarily officers and directors, underlying vested stock purchase options.

Jupiter Neurosciences files an amendment to its Form S-1 registration statement to include the consent of Assurance Dimensions and update the exhibit index.

Shuttle Pharmaceuticals Holdings seeks to raise capital through a public offering of common stock and warrants to advance its cancer treatment pipeline.

Aldel Financial II Inc., a blank check company, has filed an amendment to its S-1 registration statement for a $200 million initial public offering.

Thoughtful Media Group files an amendment to its S-1 registration statement, outlining its IPO plans and a resale prospectus for existing stockholders.

Applied Digital Corporation has filed a registration statement for the resale of up to 13,617,521 shares of its common stock by selling stockholders.

Tenon Medical is registering the resale of up to 2.4 million shares of common stock by a selling stockholder after a warrant inducement offer.

Job Aire Group, a professional services company specializing in aviation staffing, has filed an S-1/A registration statement for an initial public offering (IPO) of 2,250,000 shares of common stock, with an estimated offering price between $4.50 and $5.50 per share.

Linkhome Holdings Inc. is moving forward with its IPO, offering 1,250,000 shares of common stock with an estimated initial price of $4.00 per share.

Toppoint Holdings Inc. files an amendment to its S-1 registration statement, outlining details of its upcoming IPO involving common stock and underwriter warrants.

Curanex Pharmaceuticals aims to raise $24.3 million through an initial public offering to fund the clinical development of its lead botanical drug candidate, Phyto-N, and other research initiatives.

Banzai International files an S-1 registration for the resale of up to 877,372 shares of Class A Common Stock, while also detailing a debt equitization plan and an amended debt repayment agreement.

Aureus Greenway Holdings Inc. is proceeding with its initial public offering, registering 3,000,000 shares of common stock and 750,000 shares from selling stockholders.

Bold Eagle Acquisition Corp., a blank check company, aims to raise $250 million through an IPO to pursue a merger, share exchange, asset acquisition, or similar business combination.

Alpha Cognition registers 22.6 million shares for resale, paving the way for potential commercial activities following FDA approval of its Alzheimer's treatment, ZUNVEYL.

Alpha Cognition aims to uplist to the Nasdaq Capital Market through a $25 million offering of common shares and pre-funded warrants, focusing on commercializing its newly FDA-approved Alzheimer's treatment.

Natures Miracle Holding Inc. is proceeding with a public offering of units and pre-funded units, alongside registering shares for resale by selling stockholders.

Crown Electrokinetics Corp. files for a resale registration statement, paving the way for potential sales of up to $100 million in common stock to Liqueous LP under a recently established purchase agreement.

The Children's Place is launching a $90 million rights offering to existing shareholders to raise capital and strengthen its financial position.

DIH Holding US, Inc. has filed an amendment to its Form S-1 registration statement to register the resale of common stock and warrants by selling securityholders.

VSee Health, Inc. files an amendment to its S-1 registration statement primarily to include exhibits related to an equity purchase agreement and commitment note.

Jet.AI Inc. registers for resale up to 30.1 million shares of common stock by a selling stockholder, including shares from Series B Preferred Stock conversion and an effectiveness fee.

DiamiR Biosciences updates its S-1 registration statement to address SEC comments and reflect financials for the quarter ended August 31, 2024, as it prepares for its initial public offering.